Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations

被引:40
作者
Tierens, A
Delabie, J [1 ]
Malecka, A
Wang, JB
Gruszka-Westwood, A
Catovsky, D
Matutes, E
机构
[1] Norweigian Canc Inst, Dept Pathol, N-0310 Oslo, Norway
[2] Norweigian Canc Inst, Dept Tumor Biol, N-0310 Oslo, Norway
[3] Univ Oslo, Radiumhosp, Oslo, Norway
[4] Royal Marsden Hosp, London SW3 6JJ, England
关键词
D O I
10.1016/S0002-9440(10)63862-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Splenic marginal zone lymphoma (also splenic lymphoma with villous lymphocytes) is a B-cell nonHodgkin's lymphoma with a characteristic morphology and phenotype. We studied the pattern of somatic hypermutation of the rearranged immunoglobulin heavy chain genes on 23 cases and have correlated these data with survival as well as immunophenotypic and genetic characteristics of the cases. Two-thirds of the cases show immunoglobulin gene mutations, half of which show evidence of antigen selection, whereas one-third of the cases show no significant mutations. On-going mutation, a feature characteristic of follicular lymphoma, was demonstrated in all six cases randomly selected for this analysis, including one case with a low number of mutations (<2%). No statistical significant correlation was found between immunoglobulin mutation status and clinical, immunophenotypic, or genetic characteristics. Our results demonstrate that on-going somatic hypermutation is a prominent feature of splenic marginal zone lymphoma with circulating villous lymphocytes. On-going somatic hypermutation has previously been demonstrated in extra-nodal and nodal marginal zone lymphoma. Our results indicate that marginal zone lymphomas at different anatomical localizations may derive from a similar B-cell subset.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 53 条
[1]   Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course [J].
Algara, P ;
Mateo, MS ;
Sanchez-Beato, M ;
Mollejo, M ;
Navas, IC ;
Romero, L ;
Solé, F ;
Salido, M ;
Florensa, L ;
Martínez, P ;
Campo, E ;
Piris, MA .
BLOOD, 2002, 99 (04) :1299-1304
[2]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[3]   IMPAIRED HUMAN-ANTIBODY RESPONSE TO THE THYMUS-INDEPENDENT ANTIGEN, DNP-FICOLL, AFTER SPLENECTOMY - IMPLICATIONS FOR POST-SPLENECTOMY INFECTIONS [J].
AMLOT, PL ;
HAYES, AE .
LANCET, 1985, 1 (8436) :1008-1011
[4]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[5]   Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas [J].
Bahler, DW ;
Miklos, JA ;
Swerdlow, SH .
BLOOD, 1997, 89 (09) :3335-3344
[6]   Splenic marginal zone lymphomas appear to originate from different B cell types [J].
Bahler, DW ;
Pindzola, JA ;
Swerdlow, SH .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (01) :81-88
[7]   USE OF IMMUNOGLOBULIN GENE REARRANGEMENTS TO SHOW CLONAL LYMPHOPROLIFERATION IN HYPER-REACTIVE MALARIAL SPLENOMEGALY [J].
BATES, I ;
BEDUADDO, G ;
BEVAN, DH ;
RUTHERFORD, TR .
LANCET, 1991, 337 (8740) :505-507
[8]   SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES IN TROPICAL WEST AFRICA [J].
BATES, I ;
BEDUADDO, G ;
RUTHERFORD, T ;
BEVAN, DH .
LANCET, 1992, 340 (8819) :575-577
[9]  
Catovsky D, 1999, SEMIN HEMATOL, V36, P148
[10]   THE CDR1 SEQUENCES OF A MAJOR PROPORTION OF HUMAN GERMLINE IG V-H GENES ARE INHERENTLY SUSCEPTIBLE TO AMINO-ACID REPLACEMENT [J].
CHANG, B ;
CASALI, P .
IMMUNOLOGY TODAY, 1994, 15 (08) :367-373